The authors reply

Affiliations

¹ Department of Emergency and Disaster Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
² Department of Anesthesiology, Critical Care, and Surgery, Duke University School of Medicine, Durham, NC.
³ Department of Medicine, University College London Hospitals NHS Foundation Trust, London, United Kingdom, and Department of Medicine and Cardio-Metabolic Programme-NIHR UCLH/UCL BRC, London, United Kingdom.
⁴ Hematology Division Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
⁵ Department of Haematology, Manchester Royal Infirmary, Manchester, United Kingdom.

Comment

Toshiaki Iba et al. Crit Care Med. 2020 Nov.

. 2020 Nov;48(11):e1160-e1161.

doi: 10.1097/CCM.0000000000004616.

¹ Department of Emergency and Disaster Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
² Department of Anesthesiology, Critical Care, and Surgery, Duke University School of Medicine, Durham, NC.
³ Department of Medicine, University College London Hospitals NHS Foundation Trust, London, United Kingdom, and Department of Medicine and Cardio-Metabolic Programme-NIHR UCLH/UCL BRC, London, United Kingdom.
⁴ Hematology Division Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
⁵ Department of Haematology, Manchester Royal Infirmary, Manchester, United Kingdom.

No abstract available

Comment on

Coagulopathy of Coronavirus Disease 2019.
Iba T, Levy JH, Levi M, Connors JM, Thachil J. Iba T, et al. Crit Care Med. 2020 Sep;48(9):1358-1364. doi: 10.1097/CCM.0000000000004458. Crit Care Med. 2020. PMID: 32467443 Free PMC article. Review.
In Response to "Coagulopathy of Coronavirus Disease 2019".
Ng J, Fan BE, Chia YW. Ng J, et al. Crit Care Med. 2020 Nov;48(11):e1159-e1160. doi: 10.1097/CCM.0000000000004545. Crit Care Med. 2020. PMID: 32897666 Free PMC article. No abstract available.

1. Ng J, Fan BE, Chia YW. In Response to “Coagulopathy of Coronavirus Disease 2019.”. Crit Care Med. 2020; 48:e1159–e1160
1. Iba T, Levy JH, Levi M, et al. Coagulopathy of coronavirus disease 2019. Crit Care Med 2020; 48:1358–1364
1. Devreese KMJ, Linskens EA, Benoit D, et al. Antiphospholipid antibodies in patients with COVID-19: A relevant observation?. J Thromb Haemost. 2020 Jul 3. [online ahead of print]
1. Wiedermann FJ, Lederer W, Mayr AJ, et al. Prospective observational study of antiphospholipid antibodies in acute lung injury and acute respiratory distress syndrome: Comparison with catastrophic antiphospholipid syndrome. Lupus. 2003; 12:462–467
1. Ranucci M, Ballotta A, Di Dedda U, et al. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost. 2020; 18:1747–1751